2m 2m 2m 2m 2m 2m 2m
UNICYCIVE THERAP (UNCY)
NASDAQ
$8.09+$0.07 (+0.81%)
Price as of Jun 23, 2026 7:38 PM EDT- $215.6MMarket Cap
- 15.56%1-Year Change
- BiotechnologyIndustry
UNICYCIVE THERAP (UNCY)
$8.09+$0.07 (+0.81%)
UNCY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.02 | ||
Change | +$0.15 (+1.91%) | ||
Open | $7.76 | ||
High | $8.44 | ||
Low | $7.71 | ||
Previous Close | $7.87 | ||
Volume | 1,753,147 | ||
30-Day Average Volume | 1,101,713 | ||
1-Week Change | 11.85% | ||
1-Month Change | -0.74% | ||
1-Year Change | 15.56% | ||
3-Year Change | -46.17% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 27.4M | ||
Total Assets | $64.4M | ||
Market Cap | $215.6M | ||
Enterprise Value | $178.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$12.8M | ||
Free Cash Flow | -$6.2M | ||
EBIT | -$12.8M | ||
EBITDA | -$12.8M | ||
Net Working Capital | $37.1M | ||
EPS | -$0.54 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 6 | ||
P/E | -15 | ||
PEG | 0 | ||
Price/Free Cash Flow | -34 | ||
Price/Operating Cash Flow | -35 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 06/20/2025 | ||
Earnings & Revenue